BofA on Jazz (JAZZ): 'We continue to see $1bn+ peak sales potential for zani in 1L GE'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 229.74 +15.30 (7.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.44 | 52 Week High | $160.00 | |||
| Open | $225.37 | 52 Week Low | $95.80 | |||
| Day High | $234.79 | P/E | 42.70 | |||
| Day Low | $218.53 | EPS | $5.38 | |||
| Volume | 1,684,030 | |||||
